long term risks of glp 1 GLP-1 medications are changing obesity treatment. But the research on long-term effects is still catching up. Stay informed. The science is moving fast. #HealthTrend #HealFrontier #GLP1 #ObesityTreatment #ModernMedicine #HealthInnovation #ClinicalInsights dangers of glp 1 drugs

Similarly, tendon attachments at the spine may develop tendinopathy

GLP-1: RAs Glucagon-like peptide-1 receptor agonists

I'm doing a very comprehensive blood test to see kind of okay, what's off and, and where do we need to plug those holes

Melanotan II is a cyclic peptide listed in official and curated chemical databases under the synonym MT-II, with PubChem CID 92432 and IUPHAR/BPS GtoPdb Ligand ID 1323 [1] [2]

Moreover, SFN is considered to possess negligible toxic effects and effectively traverses the bloodbrain barrier in mice after intraperitoneal administration, potentially increasing brain-derived neurotrophic factor (BDNF) levels and enhancing dendritic spine density due to its direct impact on neurons, while also providing protection against oxidative stress via the Keap1-Nrf2 pathway (102)